Oral anticoagulants and non-cardioembolic stroke prevention

被引:1
|
作者
Schachter, Michael E. [1 ]
Tran, Huyen A. [2 ]
Anand, Sonia S. [3 ]
机构
[1] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[2] Australian Ctr Blood Dis, Melbourne, Vic, Australia
[3] McMaster Univ, Dept Med, Hamilton Hlth Sci Corp, Hamilton, ON, Canada
关键词
anticoagulant; antiplatelet; intracranial thrombosis; prevention; stroke; transient ischemic attack;
D O I
10.1177/1358863X07086191
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The use of anticoagulants for secondary prevention following non-cardioembolic ischemic stroke is controversial. This systematic review evaluates the safety and efficacy of oral anticoagulation compared with control and antiplatelet therapy.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [31] Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
    Valis, Martin
    Klimova, Blanka
    Novotny, Michal
    Herzig, Roman
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [32] Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE) : a randomised controlledtrial
    Kelly, Peter
    Lemmens, Robin
    Weimar, Christian
    Walsh, Cathal
    Purroy, Francisco
    Barber, Mark
    Collins, Ronan
    Cronin, Simon
    Czlonkowska, Anna
    Desfontaines, Philippe
    De Pauw, Adinda
    Evans, Nicholas Richard
    Fischer, Urs
    Fonseca, Catarina
    Forbes, John
    Hill, Michael D.
    Jatuzis, Dalius
    Korv, Janika
    Kraft, Peter
    Kruuse, Christina
    Lynch, Catherine
    McCabe, Dominick
    Mikulik, Robert
    Murphy, Sean
    Nederkoorn, Paul
    O'Donnell, Martin
    Sandercock, Peter
    Schroeder, Bernadette
    Shim, Gek
    Tobin, Katrina
    Williams, David J.
    Price, Christopher
    LANCET, 2024, 404 (10448): : 125 - 133
  • [33] Prevalence of asymptomatic peripheral artery disease in patients with non-cardioembolic ischemic stroke
    Alvarez-Sabin, J.
    Gil-Nunez, A.
    Quintana, M.
    Barbera, G.
    NEUROLOGIA, 2009, 24 (06): : 366 - 372
  • [34] New oral anticoagulants in the prevention of stroke
    Jarzabek, Konrad
    Bakowski, Dawid
    Wozakowska-Kaplon, Beata
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2013, 29 (03) : 264 - 266
  • [35] Oral anticoagulants for secondary prevention of stroke
    Hart, RG
    CEREBROVASCULAR DISEASES, 1997, 7 : 24 - 29
  • [36] Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke
    Ding, Lingling
    Liu, Yu
    Meng, Xia
    Jiang, Yong
    Lin, Jinxi
    Cheng, Si
    Xu, Zhe
    Zhao, Xingquan
    Li, Hao
    Wang, Yongjun
    Li, Zixiao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [37] Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke
    Yang, Pil-Sung
    Pak, Hui-Nam
    Park, Dong-Hyuk
    Yoo, Joonsang
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Young Dae
    Nam, Hyo Suk
    Joung, Boyoung
    Lee, Moon-Hyoung
    Heo, Ji Hoe
    PLOS ONE, 2018, 13 (07):
  • [38] Prevalence of the metabolic syndrome in patients with transient ischemic attack or non-cardioembolic stroke
    Gil-Nunez, A.
    Alvarez-Sabin, J.
    Quintana, M.
    Barbera, G.
    NEUROLOGIA, 2009, 24 (07): : 446 - 453
  • [39] Hyperhomocysteinemia affects the stroke severity and the risk of disabling deficit in non-cardioembolic stroke in young adults
    Filimonov, D.
    Yevtushenko, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E374 - E374
  • [40] Effects of policosanol in the functional recovery of non-cardioembolic ischemic stroke hypertensive patients
    Sanchez-Lopez, Javier
    Fernandez-Travieso, Julio C.
    Illnait-Ferrer, Jose
    Fernandez-Dorta, Lilia
    Mendoza-Castano, Sarahi
    Mas-Ferreiro, Rosa
    Mesa-Angarica, Meilis
    Reyes-Suarez, Pablo
    REVISTA DE NEUROLOGIA, 2018, 67 (09) : 331 - 338